Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone (Q57693906)
Jump to navigation
Jump to search
scientific article published on 25 September 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone |
scientific article published on 25 September 2013 |
Statements
Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone (English)
D Bianchini
A Rodriguez-Vida
A Omlin
C Pezaro
R Ferraldeschi
A Zivi
S Chowdhury
J S de Bono
25 September 2013